IS2123B - Indól-2,3-díon-3-oxíms afleiður - Google Patents

Indól-2,3-díon-3-oxíms afleiður

Info

Publication number
IS2123B
IS2123B IS4748A IS4748A IS2123B IS 2123 B IS2123 B IS 2123B IS 4748 A IS4748 A IS 4748A IS 4748 A IS4748 A IS 4748A IS 2123 B IS2123 B IS 2123B
Authority
IS
Iceland
Prior art keywords
dione
het
oxime derivatives
indole
ring
Prior art date
Application number
IS4748A
Other languages
English (en)
Icelandic (is)
Other versions
IS4748A (is
Inventor
Wuetjen Frank
Drejer Jorgen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of IS4748A publication Critical patent/IS4748A/is
Publication of IS2123B publication Critical patent/IS2123B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4748A 1996-10-01 1998-05-18 Indól-2,3-díon-3-oxíms afleiður IS2123B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (2)

Publication Number Publication Date
IS4748A IS4748A (is) 1998-05-18
IS2123B true IS2123B (is) 2006-07-14

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4748A IS2123B (is) 1996-10-01 1998-05-18 Indól-2,3-díon-3-oxíms afleiður

Country Status (29)

Country Link
US (3) USRE38200E1 (ru)
EP (1) EP0869958B1 (ru)
JP (1) JP3319762B2 (ru)
KR (1) KR100492052B1 (ru)
CN (1) CN1093859C (ru)
AT (1) ATE286052T1 (ru)
AU (1) AU716435B2 (ru)
BG (1) BG63874B1 (ru)
BR (1) BR9706765A (ru)
CA (1) CA2238410C (ru)
CZ (1) CZ297938B6 (ru)
DE (1) DE69732090T2 (ru)
DK (1) DK0869958T3 (ru)
EE (1) EE9800144A (ru)
ES (1) ES2235253T3 (ru)
HK (1) HK1017682A1 (ru)
HU (1) HU225145B1 (ru)
IL (1) IL124563A (ru)
IS (1) IS2123B (ru)
NO (1) NO310722B1 (ru)
NZ (1) NZ330456A (ru)
PL (1) PL193041B1 (ru)
PT (1) PT869958E (ru)
RU (1) RU2190612C2 (ru)
SI (1) SI0869958T1 (ru)
SK (1) SK282729B6 (ru)
TR (1) TR199800956T1 (ru)
UA (1) UA54403C2 (ru)
WO (1) WO1998014447A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (ru) * 1996-10-01 2003-03-17 Н'Юросерч А/С Производные индол-2,3-дион-3-оксима, фармацевтическая композиция, способ лечения расстройства или заболевания млекопитающих, в том числе человека и способ получения производных индол-2,3-дион-3-оксима
EP1066037B1 (en) * 1998-03-31 2004-12-29 Neurosearch A/S Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
WO2000071102A2 (en) * 1999-05-19 2000-11-30 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
EP1736468A3 (en) * 2000-01-24 2007-01-03 NeuroSearch A/S Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
EP1361878A1 (en) * 2001-02-15 2003-11-19 Neurosearch A/S Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
ATE307133T1 (de) 2001-07-13 2005-11-15 Pharmacia & Upjohn Co Llc Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden
AU2003250323A1 (en) * 2002-08-22 2004-03-11 Neurosearch A/S A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
BRPI0618863A2 (pt) * 2005-11-23 2016-09-13 Painceptor Pharma Corp métodos de modular a atividade de um canal iônico dependente e de tratar dor, uma transtorno associado aos sistemas genitourinário ou gastrointestinal em um indivíduo e, composto
WO2007115403A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080004306A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
JP6804469B2 (ja) 2015-04-29 2020-12-23 ヤンセン ファーマシューティカ エヌ.ベー. ベンゾイミダゾロン及びベンゾチアゾロン化合物並びにampa受容体調節因子としてのそれらの使用
SI3288940T1 (sl) 2015-04-29 2021-07-30 Janssen Pharmaceutica Nv Azabenzimidazoli in njihova uporaba kot modulatorji AMPA-receptorja
WO2016176457A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
JP6811187B2 (ja) * 2015-04-29 2021-01-13 ヤンセン ファーマシューティカ エヌ.ベー. インドロン化合物、及びampa受容体調節因子としてのそれらの使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204914A (es) * 1991-08-28 1993-07-01 Frank Watjen Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
WO1994026747A1 (en) * 1993-05-13 1994-11-24 Neurosearch A/S Ampa antagonists and a method of treatment therewith
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
AU686888B2 (en) * 1994-09-14 1998-02-12 Neurosearch A/S Fused indole and quinoxaline derivatives, their preparation and use
JP3164371B2 (ja) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ インドール−2,3−ジオン−3−オキシム誘導体、その製造および使用
UA54403C2 (ru) * 1996-10-01 2003-03-17 Н'Юросерч А/С Производные индол-2,3-дион-3-оксима, фармацевтическая композиция, способ лечения расстройства или заболевания млекопитающих, в том числе человека и способ получения производных индол-2,3-дион-3-оксима

Also Published As

Publication number Publication date
CN1093859C (zh) 2002-11-06
CN1207100A (zh) 1999-02-03
CZ297938B6 (cs) 2007-05-02
US6124285A (en) 2000-09-26
WO1998014447A1 (en) 1998-04-09
AU716435B2 (en) 2000-02-24
AU4376897A (en) 1998-04-24
IS4748A (is) 1998-05-18
KR19990071823A (ko) 1999-09-27
MX9804365A (es) 1998-10-31
PL327073A1 (en) 1998-11-23
HUP9901630A3 (en) 2001-11-28
SI0869958T1 (en) 2005-06-30
CZ160698A3 (cs) 1998-10-14
NO982466D0 (no) 1998-05-29
IL124563A (en) 2005-05-17
HK1017682A1 (en) 1999-11-26
HU225145B1 (en) 2006-07-28
ES2235253T3 (es) 2005-07-01
NO310722B1 (no) 2001-08-20
EP0869958A1 (en) 1998-10-14
SK282729B6 (sk) 2002-11-06
HUP9901630A2 (hu) 1999-08-30
US6693111B1 (en) 2004-02-17
NZ330456A (en) 1998-11-25
SK67698A3 (en) 1998-11-04
EE9800144A (et) 1998-10-15
CA2238410C (en) 2007-06-12
JP2000501432A (ja) 2000-02-08
TR199800956T1 (xx) 1998-12-21
JP3319762B2 (ja) 2002-09-03
RU2190612C2 (ru) 2002-10-10
BG102489A (en) 1999-04-30
KR100492052B1 (ko) 2005-09-30
BR9706765A (pt) 1999-09-14
DE69732090D1 (de) 2005-02-03
ATE286052T1 (de) 2005-01-15
PT869958E (pt) 2005-05-31
PL193041B1 (pl) 2007-01-31
IL124563A0 (en) 1998-12-06
DK0869958T3 (da) 2005-04-18
EP0869958B1 (en) 2004-12-29
NO982466L (no) 1998-07-31
UA54403C2 (ru) 2003-03-17
BG63874B1 (bg) 2003-04-30
CA2238410A1 (en) 1998-04-09
USRE38200E1 (en) 2003-07-22
DE69732090T2 (de) 2005-12-29

Similar Documents

Publication Publication Date Title
IS2123B (is) Indól-2,3-díon-3-oxíms afleiður
EA200100970A1 (ru) Аминопроизводные как ингибиторы протеазы
ATE157355T1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
HUP0204418A2 (hu) NHE-1 inhibitor hatású N-[(helyettesített öttagú, di- vagy triaza-, kétszeresen telítetlen gyűrű)-karbonil]-guanidin-származékok és alkalmazásuk
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
ES2162466T3 (es) Derivados de 1,2,4-triazolo(4,3-b)pirido(3,2-d)piridazina y composiciones farmaceuticas que los contienen.
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
NO305287B1 (no) AMPA antagonister
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
DE59710816D1 (de) Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung
DE69231546D1 (de) Endothelin Antagonisten
IL91648A (en) Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
HUP0105406A2 (hu) Imidazo[1,2-a]kinolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
EA199700205A1 (ru) Прокинетические оксадиазолы
AR036554A1 (es) Coniosulfuros y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
ATE120749T1 (de) (3h,7h>thiazolo(3,4-a>pyridine mit antiasthmatischer und entzündungshemmender wirkung auf die atmungswege.
ES455436A1 (es) Procedimiento de preparacion de acidos tienotienilcarbonife-nilalcanoicos.